BioZyme® Incorporated, a world-wide leader in animal health through nutrition and microbial products and services has acquired Cogent Solutions Group, LLC (“CSG”). CSG is a trailblazer in the research, development and production of bioactive polysaccharides.
CSG’s MHB3® Hyaluronan just received its 7th U.S. Patent for supporting joint health in mammals. Hyaluronex®, Baxyl®, Runovia®, and Trixsyn® are joint support category leaders for their respective species. Similarly, CSG’s Phygest™, Alimend® and Alicaid® use proprietary polysaccharides to provide stomach comfort for people, horses and companion animals, respectively.
With this acquisition, BioZyme further extends its reach into animal health and welfare and lays the foundation to expand its offerings to people. BioZyme’s innovative and popular products include VitaFerm®, Vita Charge®, Vitalize®, Amaferm®, DuraFerm®, AO-Biotics® and Sure Champ®.
According to Bob Norton, CEO of BioZyme, “This acquisition makes perfect sense for two thought-leaders like these two companies to come together.”
Jim Smith, CEO of CSG echoed that sentiment. “We look forward to working with BioZyme’s team on the common goal of improving the health and comfort of people and animals using unique compounds from nature.”